BACKGROUND: We examined host genetic factors to identify those more common in individuals whose human papillomavirus (HPV) infections were most likely to persist and progress to cervical intraepithelial neoplasia grade 3 (CIN3) and cancer. METHODS: We genotyped 92 single-nucleotide polymorphisms (SNPs) from 49 candidate immune response and DNA repair genes obtained from 469 women with CIN3 or cancer, 390 women with persistent HPV infections (median duration, 25 months), and 452 random control subjects from the 10,049-woman Guanacaste Costa Rica Natural History Study. We calculated odds ratios and 95% confidence intervals (CIs) for the association of SNP and haplotypes in women with CIN3 or cancer and HPV persistence, compared with random control subjects. RESULTS: A SNP in the Fanconi anemia complementation group A gene (FANCA) (G501S) was associated with increased risk of CIN3 or cancer. The AG and GG genotypes had a 1.3-fold (95% CI, 0.95-1.8-fold) and 1.7-fold (95% CI, 1.1-2.6-fold) increased risk for CIN3 or cancer, respectively (P(trend) = .008; referent, AA). The FANCA haplotype that included G501S also conferred increased risk of CIN3 or cancer, as did a different haplotype that included 2 other FANCA SNPs (G809A and T266A). A SNP in the innate immune gene IRF3 (S427T) was associated with increased risk for HPV persistence (P(trend) = .009). CONCLUSIONS: Our results require replication but support the role of FANCA variants in cervical cancer susceptibility and of IRF3 in HPV persistence.
BACKGROUND: We examined host genetic factors to identify those more common in individuals whose humanpapillomavirus (HPV) infections were most likely to persist and progress to cervical intraepithelial neoplasia grade 3 (CIN3) and cancer. METHODS: We genotyped 92 single-nucleotide polymorphisms (SNPs) from 49 candidate immune response and DNA repair genes obtained from 469 women with CIN3 or cancer, 390 women with persistent HPV infections (median duration, 25 months), and 452 random control subjects from the 10,049-womanGuanacaste Costa Rica Natural History Study. We calculated odds ratios and 95% confidence intervals (CIs) for the association of SNP and haplotypes in women with CIN3 or cancer and HPV persistence, compared with random control subjects. RESULTS: A SNP in the Fanconi anemia complementation group A gene (FANCA) (G501S) was associated with increased risk of CIN3 or cancer. The AG and GG genotypes had a 1.3-fold (95% CI, 0.95-1.8-fold) and 1.7-fold (95% CI, 1.1-2.6-fold) increased risk for CIN3 or cancer, respectively (P(trend) = .008; referent, AA). The FANCA haplotype that included G501S also conferred increased risk of CIN3 or cancer, as did a different haplotype that included 2 other FANCA SNPs (G809A and T266A). A SNP in the innate immune gene IRF3 (S427T) was associated with increased risk for HPV persistence (P(trend) = .009). CONCLUSIONS: Our results require replication but support the role of FANCA variants in cervical cancer susceptibility and of IRF3 in HPV persistence.
Authors: Daniel J Schaid; Charles M Rowland; David E Tines; Robert M Jacobson; Gregory A Poland Journal: Am J Hum Genet Date: 2001-12-27 Impact factor: 11.025
Authors: M Schiffman; R Herrero; A Hildesheim; M E Sherman; M Bratti; S Wacholder; M Alfaro; M Hutchinson; J Morales; M D Greenberg; A T Lorincz Journal: JAMA Date: 2000-01-05 Impact factor: 56.272
Authors: G A Stanczuk; E N Sibanda; C Perrey; M Chirara; V Pravica; I V Hutchinson; S A Tswana Journal: Int J Cancer Date: 2001-12-15 Impact factor: 7.396
Authors: R Herrero; A Hildesheim; C Bratti; M E Sherman; M Hutchinson; J Morales; I Balmaceda; M D Greenberg; M Alfaro; R D Burk; S Wacholder; M Plummer; M Schiffman Journal: J Natl Cancer Inst Date: 2000-03-15 Impact factor: 13.506
Authors: Mahboobeh Safaeian; Koen Quint; Mark Schiffman; Ana Cecilia Rodriguez; Sholom Wacholder; Rolando Herrero; Allan Hildesheim; Raphael P Viscidi; Wim Quint; Robert D Burk Journal: J Natl Cancer Inst Date: 2010-11-23 Impact factor: 13.506
Authors: Elizabeth E Hoskins; Richard J Morreale; Stephen P Werner; Jennifer M Higginbotham; Laimonis A Laimins; Paul F Lambert; Darron R Brown; Maura L Gillison; Gerard J Nuovo; David P Witte; Mi-Ok Kim; Stella M Davies; Parinda A Mehta; Melinda Butsch Kovacic; Kathryn A Wikenheiser-Brokamp; Susanne I Wells Journal: J Virol Date: 2012-05-23 Impact factor: 5.103
Authors: Luis Orlando Pérez; Andrea Crivaro; Gisela Barbisan; Lucia Poleri; Carlos Daniel Golijow Journal: Pathol Oncol Res Date: 2013-03-29 Impact factor: 3.201
Authors: Sophia S Wang; Paula Gonzalez; Kai Yu; Carolina Porras; Qizhai Li; Mahboobeh Safaeian; Ana Cecilia Rodriguez; Mark E Sherman; Concepcion Bratti; Mark Schiffman; Sholom Wacholder; Robert D Burk; Rolando Herrero; Stephen J Chanock; Allan Hildesheim Journal: PLoS One Date: 2010-01-13 Impact factor: 3.240